ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NP41125 Immunosuppressant Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · compiled

Tender information last checkedLast checked 30 Sept 2026, 01:34.

Opportunity overview

Supply of immunosuppressant medicines to NHS Scotland.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Astellas

Match pending…
Shared contract value
£3.4m
Awarded
Not supplied
Contract signed
13 Aug 2025
Suppliers
One of 7 awarded suppliers
Award ID
052357-2025-NP41125-1
Status
active
Location
Chertsey, UKM, KT16 0RS, United Kingdom

Chiesi Limited

Matched by exact name
Shared contract value
£3.4m
Awarded
Not supplied
Contract signed
13 Aug 2025
Suppliers
One of 7 awarded suppliers
Award ID
052357-2025-NP41125-1
Status
active
Location
Manchester, UKM, M22 5LG, United Kingdom

Pfizer Ltd

Matched by exact name
Shared contract value
£3.4m
Awarded
Not supplied
Contract signed
13 Aug 2025
Suppliers
One of 7 awarded suppliers
Award ID
052357-2025-NP41125-1
Status
active
Location
Tadworth, UKM, KT20 7NS, United Kingdom

Roche Products Ltd

Matched by exact name
Shared contract value
£3.4m
Awarded
Not supplied
Contract signed
13 Aug 2025
Suppliers
One of 7 awarded suppliers
Award ID
052357-2025-NP41125-1
Status
active
Location
Welwyn Garden City, UKM, AL7 1TW, United Kingdom

Rosemont Pharmaceuticals

Matched by normalised name
Shared contract value
£3.4m
Awarded
Not supplied
Contract signed
13 Aug 2025
Suppliers
One of 7 awarded suppliers
Award ID
052357-2025-NP41125-1
Status
active
Location
Leeds, UKM, LS11 9XE, United Kingdom

Sandoz

Match pending…
Shared contract value
£3.4m
Awarded
Not supplied
Contract signed
13 Aug 2025
Suppliers
One of 7 awarded suppliers
Award ID
052357-2025-NP41125-1
Status
active
Location
Camberley, Surrey, UKM, GU15 3YL, United Kingdom

Teva UK Ltd

Matched by exact name
Shared contract value
£3.4m
Awarded
Not supplied
Contract signed
13 Aug 2025
Suppliers
One of 7 awarded suppliers
Award ID
052357-2025-NP41125-1
Status
active
Location
Castleford, UKM, WF10 5HX, United Kingdom

Classification

  • CPV33600000 — Pharmaceutical products

Lots

  • Supply of Immunosuppressant Medicines to NHS Scotland. The Authority intends to award this framework as an unranked multi-supplier framework per line to a maximum of five (5) Framework Participants. This has been awarded to the seven (7) suppliers.£3.1m

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-051425
Status
complete
Has Recurrence
No
Review Details
The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Procurement Method
open
Main Procurement Category
goods
Procurement Method Details
Open procedure

Covered By

GPA

Bid Opening

Date
16 Jun 2025, 12:00

Legal basis

Id
32014L0024
Scheme
CELEX

Techniques

Has Framework Agreement
Yes

Framework Agreement

Maximum Participants
9,999,999

Expected award period

Starts
16 Jun 2025, 12:00

Tender Period

Ends
16 Jun 2025, 12:00

Contract terms

Has Electronic Payment
Yes
Has Electronic Ordering
Yes
Electronic Invoicing Policy
allowed

Classification

Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Submission terms

Languages

en

Bid Validity Period

Duration In Days
90

Submission Method

electronicSubmission

Selection criteria

Criteria

Criterion 1
Type
suitability
Description
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015

Applies To

supplier
Criterion 2
Type
technical
Minimum
(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b)Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c)Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. (d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder’s carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.
Description
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.

Applies To

supplier

Lots and requirements

Entry 1
Id
1
Status
cancelled
Has Options
No
Has Renewal
No
Description
Supply of Immunosuppressant Medicines to NHS Scotland. The Authority intends to award this framework as an unranked multi-supplier framework per line to a maximum of five (5) Framework Participants. This has been awarded to the seven (7) suppliers.

Value

Amount
3,144,000
Currency
GBP

Award criteria

Criteria

Criterion 1
Name
Logistics
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
1,440

Submission terms

Variant Policy
notAllowed

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Buyer, suppliers and contacts

Organisation 1
Id
GB-FTS-115937
Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Roles

buyer
centralPurchasingBody

Address

Region
UKM
Locality
Edinburgh
Postal Code
EH12 9EB
Country Name
United Kingdom
Street Address
1 South Gyle Crescent

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Legal Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contact

Name
Ross Glen
Organisation 2
Id
GB-FTS-324
Name
Sheriff Court House

Roles

reviewBody

Address

Locality
Edinburgh
Postal Code
EH1 1LB
Country Name
United Kingdom
Street Address
27 Chambers Street

Details

Identifier

Legal Name
Sheriff Court House

Contact

Telephone
+44 1312252525
Organisation 3
Id
GB-FTS-159230
Name
Astellas

Roles

supplier

Address

Region
UKM
Locality
Chertsey
Postal Code
KT16 0RS
Country Name
United Kingdom
Street Address
2000 Hillswood Drive

Details

Scale
large

Identifier

Legal Name
Astellas
Organisation 4
Id
GB-FTS-11335
Name
Chiesi Limited

Roles

supplier

Address

Region
UKM
Locality
Manchester
Postal Code
M22 5LG
Country Name
United Kingdom
Street Address
333 Styal Road

Details

Scale
large

Identifier

Legal Name
Chiesi Limited
Organisation 5
Id
GB-FTS-4549
Name
Pfizer Ltd

Roles

supplier

Address

Region
UKM
Locality
Tadworth
Postal Code
KT20 7NS
Country Name
United Kingdom
Street Address
Walton Oaks, Dorking Road, Surrey

Details

Scale
large

Identifier

Legal Name
Pfizer Ltd
Organisation 6
Id
GB-FTS-3470
Name
Roche Products Ltd

Roles

supplier

Address

Region
UKM
Locality
Welwyn Garden City
Postal Code
AL7 1TW
Country Name
United Kingdom
Street Address
6 Falcon Way, Shire Park

Details

Scale
large

Identifier

Legal Name
Roche Products Ltd
Organisation 7
Id
GB-FTS-50485
Name
Rosemont Pharmaceuticals

Roles

supplier

Address

Region
UKM
Locality
Leeds
Postal Code
LS11 9XE
Country Name
United Kingdom
Street Address
Braithwaite Street

Details

Scale
large

Identifier

Legal Name
Rosemont Pharmaceuticals
Organisation 8
Id
GB-FTS-95765
Name
Sandoz

Roles

supplier

Address

Region
UKM
Locality
Camberley, Surrey
Postal Code
GU15 3YL
Country Name
United Kingdom
Street Address
Park View, Riverside Way, Watchmoor Park

Details

Scale
large

Identifier

Legal Name
Sandoz
Organisation 9
Id
GB-FTS-93451
Name
Teva UK Ltd

Roles

supplier

Address

Region
UKM
Locality
Castleford
Postal Code
WF10 5HX
Country Name
United Kingdom
Street Address
Ridings Point, Whistler Drive, Glasshoughton

Details

Scale
large

Identifier

Legal Name
Teva UK Ltd

Award information

Award 1
Id
052357-2025-NP41125-1
Status
active

Suppliers

Supplier 1
Id
GB-FTS-159230
Name
Astellas
Supplier 2
Id
GB-FTS-11335
Name
Chiesi Limited
Supplier 3
Id
GB-FTS-4549
Name
Pfizer Ltd
Supplier 4
Id
GB-FTS-3470
Name
Roche Products Ltd
Supplier 5
Id
GB-FTS-50485
Name
Rosemont Pharmaceuticals
Supplier 6
Id
GB-FTS-95765
Name
Sandoz
Supplier 7
Id
GB-FTS-93451
Name
Teva UK Ltd

Related lots

1

Contracts and changes

Entry 1
Id
052357-2025-NP41125-1
Status
active
Award ID
052357-2025-NP41125-1
Date Signed
14 Aug 2025, 00:00

Value

Amount
3,437,024
Currency
GBP

Recorded locations

  • Buyer location · Edinburgh · UKM · EH12 9EB · United Kingdom
  • Delivery location · UKM

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-051425-2025-08-29T11:17:53+01:00compiled ·